Mustang Bio, Inc. (MBIO) SEC Filing 8-K Material Event for the period ending Monday, September 30, 2019

Mustang Bio, Inc.

CIK: 1680048 Ticker: MBIO

View differences made from one to another to evaluate Mustang Bio, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Mustang Bio, Inc..


Assess how Mustang Bio, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Mustang Bio, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors



Material Contracts, Statements, Certifications & more

Mustang Bio, Inc. provided additional information to their SEC Filing as exhibits

Ticker: MBIO
CIK: 1680048
Form Type: 8-K Corporate News
Accession Number: 0001144204-19-046520
Submitted to the SEC: Mon Sep 30 2019 4:30:37 PM EST
Accepted by the SEC: Mon Sep 30 2019
Period: Monday, September 30, 2019
Industry: Pharmaceutical Preparations
  1. Bylaw Change
  2. Financial Exhibit

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: